Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook ...

Every week, reporter Jim Weiker rounds up the biggest business news of the week in his Breaking Ground newsletter. Check out his latest.

James Bradner; Executive Vice President, Research and Development, and Chief Scientific Officer; Amgen Inc Peter Griffith; Executive Vice President and Chief Financial Officer; Amgen Inc Good ...

Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were ...

Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

But here at Amgen, we're on to Phase III. Oh, yes. And on the CVOT study, we won't share any details today regarding the CVOT study. But with our 2 Phase III chronic weight management programs now ...

Amgen (NASDAQ:AMGN) reported a 24% rise in first-quarter profit, fueled by strong product sales, while reaffirming full-year ...

While pharma manufacturing deals in the US increased, large cuts to research and regulatory agencies increased concerns for ...

Amgen Announces $900 Million Manufacturing Expansion, Creation of 350 New Jobs in Ohio "Today's investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients ...